A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors

Clinical trial NCT06235983 · COMPLETED

Trial details

NCT number: NCT06235983
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-02-29
Primary completion: 2025-07-02
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.